Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ovon
    Junior Member
    • Feb 2016
    • 4

    #1

    Looking for advice on generating a transcriptome from mapped .bam or .sam files

    Hello all. I'm starting off here with something fairly complex, I guess.

    I'm looking for some advice because I'm starting a new project and I haven't done this sort of thing before.

    I've got a few samples worth of RNAseq reads and I'd like to generate expression information with them. They are human, but likely to contain sequences that are not in an existing reference transcriptomes. The read depth is also not very high, so I'm hesitant to just use the genome as a reference when generating expression data.

    My plan right now is to map them to the current version of the human genome using STAR, then to use the alignments generated to produce a fasta file that has consensus sequences for everything aligned.

    From there I can use Sailfish or Salmon to get read counts, RPKM, etc, and compare my samples using some kind of differential expression analysis in R. This part I'm solid on, it's the middle step that I'm not so sure about.

    Does anyone think that generating a reference transcriptome this way is inadvisable (and why)?

    If this sounds reasonable, what do you think is the best way to do so? I see that Trinity has a genome guided transcriptome generation option. I'd like to try that out. If not, I also see that there are ways to get just the aligned portions of a .bam file in .fasta format. Seems like a relatively convoluted process, though. I'd prefer to keep things relatively simple where possible.

    One last thing, I'm not sure about preserving annotations for either of these options. So I'm open to advice on how to do that no matter what route I end up going.

    Thanks in advance!
    Last edited by ovon; 02-19-2016, 04:37 PM. Reason: typo check
  • Brian Bushnell
    Super Moderator
    • Jan 2014
    • 2709

    #2
    BBMap is, probably, substantially more sensitive for finding novel isoforms/splice-sites from low-coverage data (the only non-default flag you would need is "maxindel=200k"). I have not directly compared it to STAR, though.

    As for generating a reference transcriptome, you might consider making a union of the official transcriptome and your experimental transcriptome prior to quantification. That way, transcripts that are already annotated, and present in your samples but in levels too low to assemble, will still become valid mapping targets.

    I think the simplest approach would probably be to combine all your data, assemble with Trinity, then deduplicate your assembled transcriptome in conjunction with an official transcriptome using Dedupe (part of the BBMap package), which also removes contained subsequences. At that point you will have all official and novel transcripts for optimal quantification. This solution is not perfect, but eukaryotic RNA-seq is always messy.

    Comment

    • ovon
      Junior Member
      • Feb 2016
      • 4

      #3
      Thanks Brian, I wasn't aware of bbmap's capabilities wrt this analysis. That is all very helpful and I think I will go ahead with your suggestions. Definitely sounds easier than what I was planning.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 10:35 AM
      0 responses
      4 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-06-2026, 07:41 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      41 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      47 views
      0 reactions
      Last Post SEQadmin2  
      Working...